Riana Van Der Linde - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Pathology|February 1, 2023

Measurable residual disease in adult acute myeloid leukaemia: evaluation of a multidimensional 'radar' flow cytometric plot analysis methodRiana van der Linde, Sandy Smith, David A Brown, et al.

Cancers|October 28, 2023

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One YearRiana van der Linde, Prudence N Gatt, Sandy Smith, et al.

Pathology|July 18, 2024

Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemiaMaxine Revoltar, Riana van der Linde, Deborah Cromer, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Pathology|February 1, 2023

Measurable residual disease in adult acute myeloid leukaemia: evaluation of a multidimensional 'radar' flow cytometric plot analysis methodRiana van der Linde, Sandy Smith, David A Brown, et al.

Cancers|October 28, 2023

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One YearRiana van der Linde, Prudence N Gatt, Sandy Smith, et al.

Pathology|July 18, 2024

Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemiaMaxine Revoltar, Riana van der Linde, Deborah Cromer, et al.

Pageof 1